Toll-Like Receptor 4 (TLR4)

Pathway Diagram

flowchart TD
    TLR4["TLR4"]
    style TLR4 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    Nf__b["Nf-Kb"]
    TLR4 -->|"activates"| Nf__b
    Als["Als"]
    TLR4 -->|"activates"| Als
    Inflammation["Inflammation"]
    TLR4 -->|"activates"| Inflammation
    Neuroinflammation["Neuroinflammation"]
    TLR4 -->|"activates"| Neuroinflammation
    Toll_Like_Receptor["Toll-Like Receptor"]
    TLR4 -->|"activates"| Toll_Like_Receptor
    TLR4 -->|"inhibits"| Inflammation
    TLR4 -->|"therapeutic target"| Als
    TLR4 -->|"regulates"| Nf__b
    TNF["TNF"]
    TNF -->|"activates"| TLR4
    style Nf__b fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style Als fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#ef5350,color:#e0e0e0
    style Toll_Like_Receptor fill:#5d4400,stroke:#ffd54f,color:#e0e0e0
    style TNF fill:#1b5e20,stroke:#81c784,color:#e0e0e0

Overview

Toll-like receptor 4 (TLR4) is a pattern recognition receptor that serves as the primary sensor for bacterial lipopolysaccharide (LPS). Expressed on microglia, astrocytes, and peripheral immune cells, TLR4 triggers innate immune responses through MyD88-dependent and TRIF-dependent signaling pathways. In the CNS, TLR4 mediates neuroinflammation and has been implicated in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions.

Structure and Domains

TLR4 is a type I transmembrane receptor with:

• Leucine-rich repeats (LRR): 22 extracellular LRRs form the ligand-binding ectodomain

• Ectodomain: Horseshoe-shaped structure for LPS and DAMP recognition

• Transmembrane domain: Single-pass membrane anchor

• TIR domain: C-terminal cytoplasmic domain for adaptor recruitment

MD-2 Association

TLR4 forms a complex with MD-2 (LY96) at the cell surface:

• MD-2 binds directly to the hydrophobic portion of LPS

• The TLR4-MD-2 complex dimerizes upon LPS binding

• Dimerization brings TIR domains together for downstream signaling

Normal Function

LPS Recognition

TLR4 detects gram-negative bacterial infections:

1. LBP transfer: LPS-binding protein transfers LPS to CD14

2. CD14 presentation: CD14 presents LPS to TLR4-MD-2

3. Dimerization: Two TLR4-MD-2-LPS complexes dimerize

4. Signal transduction: TIR adaptors recruited to cytoplasmic domain

Signaling Pathways

TLR4 activates two distinct pathways:

Role in Neurodegeneration

Alzheimer’s Disease

TLR4 contributes to AD pathogenesis through multiple mechanisms:

• Aβ recognition: TLR4 can bind amyloid-β and trigger microglial activation^{1The LPS receptor (CD14) links innate immunity with Alzheimer's disease2004 · FASEB J · PMID 15177665Open reference}

• Neuroinflammation: TLR4 activation sustains chronic inflammation in AD brain

• DAMP sensing: HMGB1 and other DAMPs from dying neurons activate TLR4

• Blood-brain barrier: LPS leakage across compromised BBB activates TLR4

Animal studies: TLR4 deficiency accelerates Aβ deposition, suggesting a complex role with both protective and detrimental effects^{2Inflammation in Alzheimer's disease and therapeutic implications2018 · Mol Cell Neurosci · DOI 10.1016/j.mcn.2018.08.008Open reference}.

Parkinson’s Disease

TLR4 is implicated in dopaminergic neuron degeneration:

• α-synuclein sensing: Aggregated α-synuclein can activate TLR4 on microglia^{3α-Synuclein induces activation of microglia via TLR4 and NF-κB signaling2011 · J Neuroinflammation · PMID 21530655Open reference}

• Gut-brain axis: Intestinal LPS reaches the brain via vagus nerve

• Neuroinflammation: TLR4-driven inflammation contributes to nigral degeneration

• MPTP models: TLR4 knockout mice are partially protected from MPTP toxicity

Amyotrophic Lateral Sclerosis

TLR4 expression is elevated in ALS:

• Microglial activation: TLR4 contributes to microglial reactivity in ALS spinal cord

• TDP-43: Cytoplasmic TDP-43 aggregates may activate TLR4

• Disease progression: TLR4 levels correlate with disease severity

Traumatic Brain Injury

TLR4 mediates post-traumatic neuroinflammation:

• DAMP release: HMGB1 and HSPs released after injury activate TLR4

• Blood-brain barrier breakdown: Allows peripheral LPS entry

• Chronic inflammation: Persistent TLR4 activation may link TBI to later neurodegeneration

Therapeutic Targeting

TLR4 Antagonists

Several strategies target TLR4 in neurodegeneration:

Anti-Inflammatory Combinations

TLR4 inhibition may synergize with other approaches:

• NLRP3 inhibitors: Dual targeting of innate immune pathways

• NSAIDs: Combine with TLR4 blockade for enhanced anti-inflammatory effect

• Microbiome modulation: Reduce systemic LPS burden

Key Interactions

Genetic Polymorphisms

TLR4 polymorphisms influence neurodegenerative disease risk:

• Asp299Gly (rs4986790): Reduced LPS responsiveness

• Thr399Ile (rs4986791): Altered signaling

• AD association: Some studies suggest modified AD risk with TLR4 variants^{4TLR4 polymorphisms and environment: implications for neurodegenerative diseases2013 · Autoimmun Rev · DOI 10.1016/j.autrev.2013.10.002Open reference}

Key Publications

1. Tahara et al. TLR4 signaling pathways in Alzheimer’s disease. Neurochem Int. 2014;75:19-26.

2. Tang et al. Toll-like receptor 4 deficiency impairs microglial activation and delays amyloid plaque formation. J Neuroinflammation. 2007;4:40.

3. Stefanova et al. α-synuclein activates TLR4-dependent microglial inflammatory responses. J Neuroinflammation. 2011;8:138.

4. Bi et al. Association of TLR4 polymorphisms with sporadic Alzheimer’s disease in a Chinese Han population. J Neuroinflammation. 2019;16(1):25.

See Also

• TLR4 Gene

• TDP-43

External Links

• UniProt: O00206

• PDB structures

• GeneCards: TLR4